Patents A Key Focus As Drug-Pricing Debate Intensifies

October 02, 2020

Intellectual Property special counsel Danielle Tully shares her insights on lawmakers’ interest in how pharmaceutical patents impact drug prices, and comments on the potential benefits of one legislative proposal.   

Read the article here.

CadwaladerNews

CadwaladerSpotlight

Making a Mark on Our Communities: Pro Bono Report 2020

Cadwalader's research and intelligence platform provides analysis on changes in U.S. financial regulation. Subscribers receive a daily newsletter interpreting new laws, rules and enforcement actions that impact financial institutions.